OOIR: Observatory of International Research

Papers

(The median citation count of International Journal of Psychiatry in Clinical Practice is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Orexin a levels of adolescents with major depressive disorder	80
Hemodynamic and white blood cells parameters in patients with first-episode psychosis: a pilot longitudinal study	61
Gender differences in empathy and clinical symptoms in chronic schizophrenia patients: a large sample study based on a Chinese Han population	46
Borderline personality disorder is an innate empathy anomaly: a scoping and narrative review	41
Prevalence of suicide attempt, suicide ideation and self-harm at diagnosis in adolescents with eating disorders	36
Plasma IL-6 levels in unmedicated, comorbidity free obsessive-compulsive disorder	33
Evolution and trends of hikikomori: a bibliometrics analysis	16
Reviewers of the year 2020	14
Exploring real-world prescribing patterns for maintenance treatment in bipolar disorders: a focus on antidepressants and benzodiazepines	13
Dopamine partial agonists: a discrete class of antipsychotics	11
Serum brain-derived neurotrophic factor and glial cell-derived neurotrophic factor in patients with first-episode depression at different ages	11
The relevance of anti-N-methyl-D-aspartate receptor encephalitis for psychiatrists	11
Real-world demographic and clinical profiles of patients with treatment-resistant depression initiated on esketamine nasal spray	10
Elevated C-reactive protein/albumin ratio in patients with methamphetamine use disorder	9
Depression and atrial fibrillation in a reciprocal liaison: a neuro-cardiac link	9
COVID-19, loneliness, social isolation and risk of dementia in older people: a systematic review and meta-analysis of the relevant literature	8
Editorial 3	8
Editorial 2	8
Prevalence, demographics, and clinical characteristics of suicide attempts in first episode drug-naïve schizophrenia patients with comorbid severe depression	8
Unexpected improvement in nicotine consumption after low-frequency repetitive magnetic stimulation	7
Association of reduced cortical thickness and psychopathological symptoms in patients with first-episode drug-naïve schizophrenia	7
Preparing for the next pandemic by understanding the impact of COVID-19 mitigation measures on patients with eating Disorders: observations from an inpatient setting	7
The impact of the number of electroconvulsive therapy sessions on relapse in major depressive disorder	7
Statement of Retraction: Efficacy and safety of vortioxetine for the treatment of major depressive disorder: a randomised double-blind placebo-controlled study	6
Agomelatine bears promising potential in treating bipolar depression– a systematic review	6

Effects of seasonality in emergency admissions for mental disorders: two years of clinical experience	6
Evaluation of serum arginine metabolic pathway markers in patients with bipolar disorder and schizophrenia	6
Sociodemographic and clinical characteristics related with hyperprolactinaemia in psychiatric clinical population	6
Effect of quetiapine on inflammation and immunity: a systematic review	6
Profile of patients attending psychiatric emergency care during the coronavirus 2019 (COVID 19) pandemic: a comparative cross-sectional study between lockdown and post-lockdown periods in Lombardy, It	5
Episodic obsessive-compulsive disorder and bipolar spectrum disorder: new evidence from a large Italian OCD sample	5
A systematic review of maternal and infant outcomes after clozapine continuation in pregnancy	5
The importance of suicide risk assessment in patients affected by neurofibromatosis	5
Editorial 1	5
Delirium in COVID-19 and post-liver transplant patients: an observational study	4
Evaluation of antineuronal antibodies and 8-OHdG in mothers of children with autism spectrum disorder: a case-control study	4
Which clinical factors and biochemical parameters are associated with late-life major depression?	4
Clinical features and predictors of non-response in severe catatonic patients treated with electroconvulsive therapy	4
Electroconvulsive therapy in depression with twin pregnancy	4
Effects of lockdown on emergency room admissions for psychiatric evaluation: an observational study from 4 centres in Italy	4
Oxytocin receptor gene single nucleotide polymorphisms in patients with bipolar disorder	4
Mirtazapine blood levels and antidepressant response	4
Engendering misunderstanding: autism and borderline personality disorder	4
Neurobiological and psychological factors to depression	4
Editorial 3	4
Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practice	4
A comparison of phenomenological, clinical and familial psychiatric features of pediatric OCD and trichotillomania	3
Health care utilisation in treatment-resistant depression: a Swedish population-based cohort study	3
The impact of obsessive-compulsive personality disorder in perfectionism	3
Psychiatric manifestations of post-COVID-19 syndrome: the potential benefit of Silexan	3
High utilisers of emergency departments: the profile and journey of patients with mental health issues	3
Assessment of compliance and relapse in patients with schizophrenia before and after the onset of COVID-19 pandemic	3
Factors associated with sick leave duration in patients suffering from major depressive disorder initiating antidepressant treatment: a real-world evidence study in Germany and Spain	3
Unmet needs in the diagnosis and treatment of Parkinson’s disease psychosis and dementia-related psychosis	3
Recollecting Hanns Hippius: a stimulating pioneer of psychopharmacology and neuroscience	3
Effect of risperidone on serum IL-6 levels in individuals with schizophrenia: a systematic review and meta-analysis	2
Depressive symptoms in the entire spectrum of cognitive ageing in Greece: evidence from the Hellenic Longitudinal Investigation of Aging and Diet (HELIAD)	2
Exploring the interplay between mitochondrial dysfunction, early life adversity and bipolar disorder	2
Adolescents with first-episode psychosis and clinical high risk in the Province of Ferrara: an audit on the implementation of a specialised early intervention program	2
Predictors of sick leave days in patients affected by major depressive disorder receiving antidepressant treatment in general practice setting in Germany	2
Confabulations in post-acute and chronic alcoholic Korsakoff’s syndrome: a cross-sectional study conducted in two centres	2
Is it possible to predict hospitalisation during intensive home treatment? A retrospective cohort study	2
Psychotic symptoms prior or concomitant to diagnosis of multiple sclerosis: a systematic review of case reports and case series	2
A preliminary investigation of Cyberchondria and its correlates in a clinical sample of patients with obsessive–compulsive disorder, anxiety and depressive disorders attending a tertiary psychiatric c	2
Editorial 4	2
Reduced ability to discriminate colours – an under-recognised feature of depressive disorders? A pilot study	2
Esketamine nasal spray in patients with treatment-resistant depression: the real-world experience in the French cohort early-access programme	2
Chronotype is associated with affective temperaments, clinical severity and worse treatment outcomes in bipolar disorders: results from a two-center, cross-sectional study	2
Thank you to reviewers	2
Assessment tools for complex post traumatic stress disorder: a systematic review	2
Hoarding behaviour: special features and complications in real-world clinical practice	2
Editorial 4	2
Effects of electroconvulsive therapy on nitrosative stress and oxidative DNA damage parameters in patients with a depressive episode	2
Validation of the Turkish version of the self-evaluation of negative symptoms scale (SNS)	2
Depression and suicidal ideation in schizophrenia spectrum disorder: a cross-sectional study from a lower middle-income country	2

Brain-Derived neurotrophic factor (BDNF) plasma level increases in patients with resistant schizophrenia treated with electroconvulsive therapy (ECT)